Package 59651-874-01

Brand: bupropion hydrochloride

Generic: bupropion hydrochloride
NDC Package

Package Facts

Identity

Package NDC 59651-874-01
Digits Only 5965187401
Product NDC 59651-874
Product ID 59651-874_8ab2cb88-9bc6-4c0c-a97b-3098dbc11a7f
Description

100 TABLET, FILM COATED in 1 BOTTLE (59651-874-01)

Marketing

Marketing Status
Marketed Since 2024-04-25
Brand bupropion hydrochloride
Generic bupropion hydrochloride
Sample Package No

Linked Drug Pages (1)

BUPROPION HYDROCHLORIDE ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "8ab2cb88-9bc6-4c0c-a97b-3098dbc11a7f", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993687", "993691"], "spl_set_id": ["6563b923-269f-40c3-b992-cbacdfca6e16"], "manufacturer_name": ["Aurobindo Pharma Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, FILM COATED in 1 BOTTLE (59651-874-01)", "package_ndc": "59651-874-01", "marketing_start_date": "20240425"}], "brand_name": "BUPROPION HYDROCHLORIDE", "product_id": "59651-874_8ab2cb88-9bc6-4c0c-a97b-3098dbc11a7f", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "59651-874", "generic_name": "BUPROPION HYDROCHLORIDE", "labeler_name": "Aurobindo Pharma Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "BUPROPION HYDROCHLORIDE", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "75 mg/1"}], "application_number": "ANDA075491", "marketing_category": "ANDA", "marketing_start_date": "20240425", "listing_expiration_date": "20261231"}